Xiao-Jun Huang Selected Research

Immunoglobulin G (IgG)

11/2021	Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies.
1/2019	Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors.
1/2019	Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical course.
8/2018	IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCT.
7/2012	Characteristics and influencing factors of CD19+ B cell reconstitution in patients following haploidentical/mismatched hematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Jun Huang Research Topics

Disease

97	Leukemia 05/2024 - 10/2005
94	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2024 - 09/2001
67	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 02/2005
50	Infections 03/2024 - 09/2001
48	Residual Neoplasm 01/2023 - 07/2008
43	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 06/2004
39	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 04/2007
32	Neoplasms (Cancer) 05/2024 - 04/2007
24	Aplastic Anemia (Anemia, Hypoplastic) 02/2024 - 04/2004
23	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 11/2007
21	Thrombocytopenia (Thrombopenia) 01/2023 - 04/2009
18	Bronchiolitis Obliterans Syndrome 11/2023 - 04/2007
17	Philadelphia Chromosome 04/2024 - 02/2005
17	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2024 - 05/2016
17	Hematologic Diseases (Blood Diseases) 04/2023 - 08/2009
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 08/2008
14	Multiple Myeloma 01/2023 - 03/2007
11	Hemorrhage 01/2023 - 01/2007
10	Acute Promyelocytic Leukemia 01/2021 - 07/2009
10	Hypoxia (Hypoxemia) 01/2018 - 04/2007
6	Viremia 06/2021 - 01/2007
5	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 06/2007
5	Pneumonia (Pneumonitis) 10/2021 - 06/2009
5	Hemorrhagic Cystitis 07/2018 - 01/2007
5	Fever (Fevers) 08/2016 - 04/2007
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2024 - 12/2007
4	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 05/2016
4	Lymphoma (Lymphomas) 01/2023 - 10/2013
4	Hepatitis B 01/2022 - 07/2004
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 10/2011
4	Disease Progression 01/2021 - 02/2012
4	Wilms Tumor (Wilm's Tumor) 11/2019 - 04/2010
3	Pathologic Complete Response 05/2024 - 06/2013
3	Virus Diseases (Viral Diseases) 03/2024 - 01/2014
3	Sepsis (Septicemia) 12/2023 - 11/2018
3	Thrombosis (Thrombus) 01/2023 - 05/2015
3	Thrombotic Microangiopathies 01/2022 - 02/2018
3	Demyelinating Diseases (Demyelinating Disease) 11/2021 - 03/2013
3	Testicular Neoplasms (Testicular Cancer) 01/2021 - 02/2014
3	Familial paroxysmal dystonia 01/2020 - 01/2018
3	Melanoma (Melanoma, Malignant) 11/2019 - 05/2010

Drug/Important Bio-Agent (IBA)

26	HLA Antigens (Human Leukocyte Antigens)IBA 12/2022 - 04/2007
22	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2023 - 04/2004
17	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2009
17	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 02/2005
15	Inosine Triphosphate (ITP)IBA 04/2024 - 05/2016
11	InterferonsIBA 01/2023 - 11/2015
10	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2023 - 12/2012
10	AntigensIBA 01/2022 - 05/2010
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 03/2007
9	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 05/2011
9	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2011
9	SteroidsIBA 01/2024 - 12/2018
9	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 08/2013
8	Tyrosine Kinase InhibitorsIBA 01/2023 - 02/2005
8	ArsenicIBA 01/2022 - 08/2013
7	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2024 - 07/2008
7	Antiviral Agents (Antivirals)IBA 03/2024 - 08/2006
7	Immunosuppressive Agents (Immunosuppressants)IBA 09/2023 - 05/2008
6	Prostaglandins FIBA 05/2024 - 10/2015
6	Methotrexate (Mexate)FDA LinkGeneric 05/2024 - 07/2008
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2024 - 08/2008
6	CytokinesIBA 05/2024 - 08/2010
6	Basiliximab FDA Link 01/2024 - 01/2020
6	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2018
6	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 11/2013
6	Messenger RNA (mRNA)IBA 08/2020 - 10/2008
5	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 06/2009
5	Immunoglobulin G (IgG)IBA 11/2021 - 07/2012
5	LigandsIBA 12/2019 - 04/2007
4	BilirubinIBA 12/2023 - 12/2021
4	AntibodiesIBA 11/2020 - 01/2008
4	Bortezomib (Velcade)FDA Link 03/2018 - 10/2011
4	rhodiolosideIBA 01/2017 - 08/2013
3	erucylphosphocholineIBA 05/2024 - 01/2018
3	GlucocorticoidsIBA 01/2023 - 07/2012
3	C-Reactive ProteinIBA 01/2023 - 08/2016
3	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2006
3	Thrombopoietin (c-mpl Ligand)IBA 01/2022 - 03/2010
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 10/2011
3	NucleophosminIBA 01/2020 - 02/2009
3	human PRRT2 proteinIBA 01/2020 - 12/2014
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 03/2012
3	realgar-indigo naturalisIBA 01/2018 - 11/2013

Therapy/Procedure

203	Hematopoietic Stem Cell Transplantation 04/2024 - 01/2007
96	Transplantation 05/2024 - 04/2004
73	Therapeutics 05/2024 - 10/2005
62	Stem Cell Transplantation 05/2024 - 07/2004
35	Drug Therapy (Chemotherapy) 05/2024 - 04/2007
17	Haploidentical Transplantation 01/2022 - 04/2007
15	Cell Transplantation 04/2023 - 04/2006
11	Immunotherapy 02/2024 - 01/2013
6	Induction Chemotherapy 10/2023 - 11/2013
6	Donor Selection 12/2022 - 04/2016
5	Aftercare (After-Treatment) 01/2021 - 05/2011
4	Homologous Transplantation 04/2023 - 03/2013
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2017 - 02/2009
3	Salvage Therapy 01/2021 - 10/2016
3	Consolidation Chemotherapy 03/2019 - 01/2016